EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients

Halle Cheplowitz iD, Nimish Patel, Alexander Kim, Cathy Logan, Nancy Law, Divya Koura, Nina Haste, Katherine Medley, Julie Trinh, Tyler Sanders, Mahnaz Taremi, Ila M Saunders

Journal of Oncology Pharmacy Practice · 2024-01 · 30 (1) · 15-18

DOI: 10.1177/10781552231165733 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 22.03.2023. Verfasst von Halle Cheplowitz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of California San Diego Health (UCSDH), San Diego, CA, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Pneumococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current guidelines for vaccination in allogeneic hematopoietic stem cell transplant (HCT) recipients recommend initiation of pneumococcal vaccination series three to six months post-HCT, with most data supporting initiation at six months due to a more robust immune response. This single-center, retrospective, observational chart review aimed to evaluate the impact of initiating the pneumococcal vaccine series at three months post-HCT compared to six months post-HCT. The primary endpoints were defined as a percentage of patients with a serologic response of >1 and >1.3 µg/mL for over 50% of the defined serotypes. Outcomes showed no difference in immunologic response between the two groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPneumococcal InfectionsHumansPneumococcal VaccinesRetrospective StudiesVaccination

Stichwörter der Autor:innen

Stem cell transplantimmune responseinfection prophylaxispneumococcal vaccination

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • Department of Pharmacy, University of California San Diego Health (UCSDH), San Diego, CA, USA.
  • UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, La Jolla, CA, USA.
  • Department of Allergy & Immunology, UCSDH, La Jolla, CA, USA.
  • Department of Infectious Disease, UCSDH, La Jolla, CA, USA.
  • Department of Medicine, Division of Bone Marrow Transplantation, UCSDH, La Jolla, CA, USA.

ORCID-Profile: Halle Cheplowitz

Zitieren

APA

Cheplowitz, H., Patel, N., Kim, A., Logan, C., Law, N., Koura, D., Haste, N., Medley, K., Trinh, J., Sanders, T., Taremi, M., & Saunders, I. M. (2024). Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of Oncology Pharmacy Practice, 30(1), 15-18. https://doi.org/10.1177/10781552231165733

Vancouver

Cheplowitz H, Patel N, Kim A, Logan C, Law N, Koura D, et al. Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of Oncology Pharmacy Practice. 2024;30(1):15-18. doi:10.1177/10781552231165733

BibTeX
@article{Cheplowitz2024,
  author = {Cheplowitz, Halle and Patel, Nimish and Kim, Alexander and Logan, Cathy and Law, Nancy and Koura, Divya and Haste, Nina and Medley, Katherine and Trinh, Julie and Sanders, Tyler and Taremi, Mahnaz and Saunders, Ila M},
  title = {Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  volume = {30},
  number = {1},
  pages = {15--18},
  doi = {10.1177/10781552231165733}
}
Kostenlos starten →